Summary: The Neuroscape Psychedelics Division was recently established at the University of California, San Francisco (UCSF) to expand psychedelic research!
According to Neuroscape, “the new division will take a unique translational research approach to integrate cutting-edge neuroscience technology with psychedelics treatment, including through a MAPS [Phase 3] trial for MDMA as a new treatment for post-traumatic stress disorder (PTSD).”
Originally appearing here.